Literature DB >> 7877803

Visual recovery in a patient with Leber hereditary optic neuropathy and the 14484 mutation.

P K Hrynchak1, M M Spafford.   

Abstract

Leber hereditary optic neuropathy (LHON) is characterized by an acute, painless, sequentially bilateral reduction in vision that usually occurs in young men. It is a maternally inherited mitochondrial genetic disease. This case report details the chronology of the bilateral vision loss of a patient found to have LHON with a mutation at nucleotide site 14484. A spontaneous recovery of visual acuity and decrease in disability occurred without a corresponding improvement in color vision, contrast sensitivity, or pattern visual evoked potential (VEP's) over a period of 6 years. The abnormal pattern VEP's were one of the indicators of the neural damage to the spatial frequency channels of the visual system. The normal flash VEP's, as determined by the critical frequency of photic driving (CFPD), suggested that most of the fibers in the luminance channels were unaffected by LHON.

Entities:  

Mesh:

Year:  1994        PMID: 7877803     DOI: 10.1097/00006324-199410000-00002

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  Clinical and electrophysiological recovery in Leber hereditary optic neuropathy with G3460A mutation.

Authors:  Eamon Sharkawi; Justyna D Oleszczuk; Graham E Holder; Joyti Raina
Journal:  Doc Ophthalmol       Date:  2012-06-10       Impact factor: 2.379

2.  Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy.

Authors:  Martina Jarc-Vidmar; Mojca Tajnik; Jelka Brecelj; Ana Fakin; Maja Sustar; Mateja Naji; Branka Stirn-Kranjc; Damjan Glavač; Marko Hawlina
Journal:  Doc Ophthalmol       Date:  2015-02-19       Impact factor: 2.379

3.  The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy.

Authors:  A Majander; A G Robson; C João; G E Holder; P F Chinnery; A T Moore; M Votruba; A Stockman; P Yu-Wai-Man
Journal:  Mitochondrion       Date:  2017-07-18       Impact factor: 4.160

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.